Effect of oral administration of tranexamic acid for refractory macular edema

Effect of oral administration of tranexamic acid for refractory macular edema - Oral administration of tranexamic acid for refractory macular edema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014601

Enrollment

Registered

2014-07-25

Start date

2014-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema

Interventions

Tranexamic acid 1500mg oral administration for 14 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Refractory macular edema 20 years and older written informed consent

Exclusion criteria

Exclusion criteria: Artificial dialysis

Design outcomes

Primary

Measure	Time frame
Visual acuity, retinal thickness	—

Countries

Japan

Contacts

Public ContactTakeyama Masayuki

Aichi medical university Department of Ophthalmology

mtakeyam@aichi-med-u.ac.jp0561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026